Search Results - "Gilham, D E"

Refine Results
  1. 1

    Ligation of the CD2 co-stimulatory receptor enhances IL-2 production from first-generation chimeric antigen receptor T cells by Cheadle, E J, Rothwell, D G, Bridgeman, J S, Sheard, V E, Hawkins, R E, Gilham, D E

    Published in Gene therapy (01-11-2012)
    “…T cells bearing chimeric antigen receptors (CARs) are broadly categorised into first- and second-generation receptors. Second-generation CARs contain a…”
    Get full text
    Journal Article
  2. 2

    CD3ζ‐based chimeric antigen receptors mediate T cell activation via cis‐ and trans‐signalling mechanisms: implications for optimization of receptor structure for adoptive cell therapy by Bridgeman, J. S., Ladell, K., Sheard, V. E., Miners, K., Hawkins, R. E., Price, D. A., Gilham, D. E.

    Published in Clinical and experimental immunology (01-02-2014)
    “…Summary Chimeric antigen receptors (CARs) can mediate redirected lysis of tumour cells in a major histocompatibility complex (MHC)‐independent manner, thereby…”
    Get full text
    Journal Article
  3. 3

    Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi‐functional and redirected T cells as effective cancer immunotherapies by Marr, L. A., Gilham, D. E., Campbell, J. D. M., Fraser, A. R.

    Published in Clinical and experimental immunology (01-02-2012)
    “…Summary OTHER THEMES PUBLISHED IN THIS IMMUNOLOGY IN THE CLINIC REVIEW SERIES Metabolic Diseases, Host Responses, Allergies, Autoinflammatory Diseases, Type 1…”
    Get full text
    Journal Article
  4. 4

    Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy by GRIFFITHS, R. W, GILHAM, D. E, DANGOOR, A, RAMANI, V, CLARKE, N. W, STERN, P. L, HAWKINS, R. E

    Published in British journal of cancer (19-09-2005)
    “…The 5T4 oncofoetal antigen is a heavily glycosylated cell surface protein found on human placental trophoblast and on diverse types of human cancer but is not…”
    Get full text
    Journal Article
  5. 5

    Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma by Baldan, V, Griffiths, R, Hawkins, R E, Gilham, D E

    Published in British journal of cancer (28-04-2015)
    “…Background: Tumour-infiltrating lymphocyte (TIL) therapy is showing great promise in the treatment of patients with advanced malignant melanoma. However, the…”
    Get full text
    Journal Article
  6. 6

    Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo by BIGLARI, A, SOUTHGATE, T. D, FAIRBAIRN, L. J, GILHAM, D. E

    Published in Gene therapy (01-04-2006)
    “…Antibody-dependent cellular cytotoxicity (ADCC) is one means by which macrophages (as well as natural killer cells and granulocytes) elicit a cytotoxic…”
    Get full text
    Journal Article
  7. 7

    Retroviral transduction of human peripheral blood lymphocytes with bcl-xL promotes in vitro lymphocyte survival in pro-apoptotic conditions by EATON, D, GILHAM, D. E, O'NEILL, A, HAWKINS, R. E

    Published in Gene therapy (01-04-2002)
    “…The prolonged in vivo survival of genetically modified effector cells is crucial to the success of any (gene-modified) adoptive cellular immunotherapy…”
    Get full text
    Journal Article
  8. 8

    Engineering T cells for cancer therapy by MANSOOR, W, GILHAM, D. E, THISTLETHWAITE, F. C, HAWKINS, R. E

    Published in British journal of cancer (14-11-2005)
    “…It is generally accepted that the immune system plays an important role in controlling tumour development. However, the interplay between tumour and immune…”
    Get full text
    Journal Article
  9. 9

    Cyclin-dependent kinase inhibitors and basement membrane interact to regulate breast epithelial cell differentiation and acinar morphogenesis by Coppock, H. A., Gilham, D. E., Howell, A., Clarke, R. B.

    Published in Cell proliferation (01-10-2007)
    “…  Objective: The cyclin‐dependent kinase inhibitors (CDKIs), p21CIP1 and p27KIP1 regulate growth and differentiation in diverse tissue types. We aimed to…”
    Get full text
    Journal Article
  10. 10

    T lymphocytes isolated from patients with advanced colorectal cancer are suitable for gene immunotherapy approaches by SHEEN, A. J, SHERLOCK, D. J, LRLAM, J, HAWKINS, R. E, GILHAM, D. E

    Published in British journal of cancer (07-04-2003)
    “…Despite improvements in treatment, the 5-year survival for metastatic colorectal cancer remains poor. Novel approaches such as gene immunotherapy are being…”
    Get full text
    Journal Article
  11. 11

    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a Substrate of Cytochrome P450 2D6:  Allosteric Effects of NADPH−Cytochrome P450 Reductase by Modi, S, Gilham, D. E, Sutcliffe, M. J, Lian, L.-Y, Primrose, W. U, Wolf, C. R, Roberts, G. C. K

    Published in Biochemistry (Easton) (15-04-1997)
    “…1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a neurotoxin that produces Parkinsonism symptoms in man, has been examined as a substrate of recombinant…”
    Get full text
    Journal Article
  12. 12

    Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization by GILHAM, D. E, CAIRNS, W, PAINE, M. J. I, MODI, S, POULSOM, R, ROBERTS, G. C. K, WOLF, C. R

    Published in Xenobiotica (1997)
    “…1. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a thermal breakdown product of synthetic 'street' heroin, is known to cause Parkinson's Disease-like…”
    Get full text
    Journal Article
  13. 13

    Development of adoptive cell therapy for cancer: a clinical perspective by Hawkins, Robert E, Gilham, David E, Debets, Reno, Eshhar, Zelig, Taylor, Naomi, Abken, Hinrich, Schumacher, Ton N, ATTACK Consortium

    Published in Human gene therapy (01-06-2010)
    “…Adoptive cellular therapy provides the promise of a potentially powerful general treatment for cancer. Although this is a complex and challenging field, there…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Retroviral transduction of human peripheral blood lymphocytes with Bcl-X(L) promotes in vitro lymphocyte survival in pro-apoptotic conditions by Eaton, D, Gilham, D E, O'Neill, A, Hawkins, R E

    Published in Gene therapy (01-04-2002)
    “…The prolonged in vivo survival of genetically modified effector cells is crucial to the success of any (gene-modified) adoptive cellular immunotherapy…”
    Get full text
    Journal Article
  16. 16

    Functional co-expression of CYP2D6 and human NADPH-cytochrome P450 reductase in Escherichia coli by Pritchard, M P, Glancey, M J, Blake, J A, Gilham, D E, Burchell, B, Wolf, C R, Friedberg, T

    Published in Pharmacogenetics (London) (01-02-1998)
    “…The polymorphic human CYP2D6 has been co-expressed with human NADPH-cytochrome P450 oxidoreductase in Escherichia coli in order to generate a functional…”
    Get more information
    Journal Article
  17. 17

    CD3[zeta]-based chimeric antigen receptors mediate T cell activation via cis- and trans-signalling mechanisms: implications for optimization of receptor structure for adoptive cell therapy by Bridgeman, J S, Ladell, K, Sheard, V E, Miners, K, Hawkins, R E, Price, D A, Gilham, D E

    Published in Clinical and experimental immunology (01-02-2014)
    “…Summary Chimeric antigen receptors (CARs) can mediate redirected lysis of tumour cells in a major histocompatibility complex (MHC)-independent manner, thereby…”
    Get full text
    Journal Article
  18. 18

    Cytokine stimulation and the choice of promoter are critical factors for the efficient transduction of mouse T cells with HIV-1 vectors by Gilham, David E., Lie-A-Ling, Michael, Taylor, Naomi, Hawkins, Robert E.

    Published in The journal of gene medicine (01-02-2010)
    “…Background HIV‐1 fails to successfully infect mouse T cells as a result of several blocks in the viral replication cycle. We investigated whether this also…”
    Get full text
    Journal Article
  19. 19
  20. 20

    O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy by Verbeek, Barbara, Southgate, Thomas D., Gilham, David E., Margison, Geoffrey P.

    Published in British medical bulletin (01-03-2008)
    “…Introduction Alkylating agents are frequently used in the chemotherapy of many types of cancer. This group of drugs mediates cell death by damaging DNA and…”
    Get full text
    Journal Article